快速宿主基因表达检测区分细菌与病毒感染
本研究纳入美国4个急诊科的623例急性呼吸道疾病或疑似脓毒症患者,评估基于45个转录本特征、在BioFire FilmArray系统上约45分钟完成的宿主反应细菌/病毒检测。以专家小组临床裁定(对基因表达和降钙素原结果盲法)为参考标准,在209例独立验证队列中,该检测对细菌感染的平均加权准确率为80.1%(95% CI 73.7-85.4%),对病毒感染为86.8%(95% CI 81.8-90.8%),显著优于降钙素原的68.7%(95% CI 62.4-75.4%)(p < 0.001)。在201例表型不确定(合并感染或微生物学阴性感染)的额外队列中表现相似。作者认为该检测能快速准确区分细菌与病毒感染,优于降钙素原,可能有助于支持更恰当的抗生素使用。
要点
- 在209例独立验证队列中,BioFire宿主反应细菌/病毒检测对细菌感染的平均加权准确率为80.1%(95% CI 73.7-85.4%),对病毒感染为86.8%(95% CI 81.8-90.8%)。
- 同一验证队列中,降钙素原的平均加权准确率为68.7%(95% CI 62.4-75.4%),宿主反应检测显著优于降钙素原(p < 0.001)。
- 验证队列中,该检测对细菌感染的AUC为0.85(95% CI 0.78-0.90),对病毒感染的AUC为0.91(95% CI 0.85-0.94)。
- 在201例表型不确定(合并感染或微生物学阴性感染)的额外队列中,检测表现相似。
- 检测在BioFire FilmArray系统上约45分钟完成,提供细菌和病毒感染的独立概率。
适用人群与场景
- 2006年至2016年从美国4个急诊科招募的623例急性呼吸道疾病或疑似脓毒症受试者(平均年龄46岁;45%男性)。
- 纳入人群包括细菌感染、病毒感染、合并感染或非感染性疾病患者。
诊断标准与关键阈值
- 参考标准为专家小组临床裁定,该裁定对基因表达和降钙素原结果盲法。
研究设计与关键结果
- 研究类型:独立队列验证研究,招募2006年至2016年,入组血样收集于RNA保存剂中并储存供后续检测;在BioFire FilmArray系统上测定45个转录本特征,约45分钟完成。
- 训练队列213例:宿主反应细菌/病毒检测对细菌感染的AUC为0.90(95% CI 0.84-0.94),对病毒感染的AUC为0.92(95% CI 0.87-0.95)。
- 独立验证队列209例:对细菌感染的AUC为0.85(95% CI 0.78-0.90),对病毒感染的AUC为0.91(95% CI 0.85-0.94)。
- 验证队列中,该检测对细菌感染的平均加权准确率为80.1%(95% CI 73.7-85.4%),对病毒感染为86.8%(95% CI 81.8-90.8%)。
- 验证队列中,降钙素原的平均加权准确率为68.7%(95% CI 62.4-75.4%),宿主反应检测显著优于降钙素原(p < 0.001)。
- 额外201例表型不确定(合并感染或微生物学阴性感染)受试者队列中,检测表现相似。
证据类型、等级与局限
- 证据类型:独立队列验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用BioFire系统测定的宿主反应细菌/病毒检测能快速准确区分细菌与病毒感染,优于降钙素原,可能有助于支持更恰当的抗生素使用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Host gene expression signatures discriminate bacterial and viral infection but have not been translated to a clinical test platform. This study enrolled an independent cohort of patients to describe and validate a first-in-class host response bacterial/viral test.
DESIGN: Subjects were recruited from 2006 to 2016. Enrollment blood samples were collected in an RNA preservative and banked for later testing. The reference standard was an expert panel clinical adjudication, which was blinded to gene expression and procalcitonin results.
SETTING: Four U.S. emergency departments.
PATIENTS: Six-hundred twenty-three subjects with acute respiratory illness or suspected sepsis.
INTERVENTIONS: Forty-five-transcript signature measured on the BioFire FilmArray System (BioFire Diagnostics, Salt Lake City, UT) in ~45 minutes.
MEASUREMENTS AND MAIN RESULTS: Host response bacterial/viral test performance characteristics were evaluated in 623 participants (mean age 46 yr; 45% male) with bacterial infection, viral infection, coinfection, or noninfectious illness. Performance of the host response bacterial/viral test was compared with procalcitonin. The test provided independent probabilities of bacterial and viral infection in ~45 minutes. In the 213-subject training cohort, the host response bacterial/viral test had an area under the curve for bacterial infection of 0.90 (95% CI, 0.84-0.94) and 0.92 (95% CI, 0.87-0.95) for viral infection. Independent validation in 209 subjects revealed similar performance with an area under the curve of 0.85 (95% CI, 0.78-0.90) for bacterial infection and 0.91 (95% CI, 0.85-0.94) for viral infection. The test had 80.1% (95% CI, 73.7-85.4%) average weighted accuracy for bacterial infection and 86.8% (95% CI, 81.8-90.8%) for viral infection in this validation cohort. This was significantly better than 68.7% (95% CI, 62.4-75.4%) observed for procalcitonin (p < 0.001). An additional cohort of 201 subjects with indeterminate phenotypes (coinfection or microbiology-negative infections) revealed similar performance.
CONCLUSIONS: The host response bacterial/viral measured using the BioFire System rapidly and accurately discriminated bacterial and viral infection better than procalcitonin, which can help support more appropriate antibiotic use.
参考来源
- Tsalik EL, Henao R, Montgomery JL, et al. Discriminating Bacterial and Viral Infection Using a Rapid Host Gene Expression Test. Crit Care Med. 2021. PMID: 33938716. doi:10.1097/CCM.0000000000005085
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。